Qiming Venture Leads $8M Series A Round In Chinese CRO Start-Up dMed
December 1, 2016 — 10:49 CST
This Data Is Locked!
This area is available only to Subscribers.
Qiming Venture Capital has led a US$8 million series A funding round in dMed Co., Ltd., a Chinese clinical contract research organization (CRO), with participation... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals